SEQ_h-21656 Evaluation of the Performance of a Non-Invasive Test for Fetal RH

Sponsor

Baylor College of Medicine

Principal Investigator

Dr. Mary Menard, Obstetrics and Gynecology

Project Run Dates

9/29/2009 to 9/28/2012

 

Summary

The objective of this study is to evaluate the performance of Sequenom's noninvasive test for fetal RHD genotype. The test uses MALDI-TOF mass spectrometry to detect DNA. The study is specifically designed to determine whether RHD typing using free fetal DNA in maternal circulation can accurately predict the neonatal RhD phenotype at birth.

 

Associated Publications and other materials

 Study Record Detail on Clinical Trials.gov